Porrazzo, M.; Nicolai, E.; Riminucci, M.; Vitale, C.; Coscia, M.; De Paoli, L.; Rago, A.; Buscicchio, G.; Maestrini, G.; Ligia, S.;
et al. Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. Cancers 2020, 12, 1773.
https://doi.org/10.3390/cancers12071773
AMA Style
Porrazzo M, Nicolai E, Riminucci M, Vitale C, Coscia M, De Paoli L, Rago A, Buscicchio G, Maestrini G, Ligia S,
et al. Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. Cancers. 2020; 12(7):1773.
https://doi.org/10.3390/cancers12071773
Chicago/Turabian Style
Porrazzo, Marika, Emanuele Nicolai, Mara Riminucci, Candida Vitale, Marta Coscia, Lorenzo De Paoli, Angela Rago, Giulia Buscicchio, Giacomo Maestrini, Silvio Ligia,
and et al. 2020. "Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy" Cancers 12, no. 7: 1773.
https://doi.org/10.3390/cancers12071773
APA Style
Porrazzo, M., Nicolai, E., Riminucci, M., Vitale, C., Coscia, M., De Paoli, L., Rago, A., Buscicchio, G., Maestrini, G., Ligia, S., Di Prima, A., Corsi, A., Caronna, R., Gaidano, G., & Mauro, F. R.
(2020). Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Chemoimmunotherapy. Cancers, 12(7), 1773.
https://doi.org/10.3390/cancers12071773